GEN-001 Plus Pembrolizumab for Patients With Advanced Refractory Biliary Tract Cancer
Genome & Company
Genome & Company
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Merck Sharp & Dohme LLC
Merck Sharp & Dohme LLC
Peking Union Medical College Hospital
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
European Organisation for Research and Treatment of Cancer - EORTC
Samsung Medical Center
University of California, San Francisco
National Institutes of Health Clinical Center (CC)